December 12, 2011
- Treatment of venous insufficiency
- Reviews Mertenile
- Analogs Nicergoline
- The price of candles Neo-Anuzol
American and British specialists united their efforts in the fight against "bad"
cholesterol
and
atherosclerosis
. Scientists have identified a new way to control cholesterol, the essence of which is as follows. Special Structures
lipoproteins
transports
fat
in blood plasma, in including and cholesterol. They are composed of protein and fat, depending on the content of these substances which can be either a high or low density. For education
atherosclerotic plaque
of the presence of high levels of cholesterol and low density lipoproteins. Thus, the low density of this material was scientists associated with the development of atherosclerosis, and as a result, the appearance
stroke
and
myocardial infarction
.
"Bad" cholesterol - This is the danger associated with low density lipoproteins, the substance. Upon binding of cholesterol to high-density structures obtained "Good" cholesterol, who is engaged in cleaning the excess fat mass from the walls of blood vessels, which reduces the risk of atherosclerosis. The aim of scientists - the struggle with "bad" cholesterol.
Team of Specialists managed to find new regulator of fat metabolism - enzyme called IDOL. Just he is responsible for the reduction of enzyme cleaning the blood from the structures of low density. Thus, it is enough to block the enzyme that does not interfere with the body excrete lipoproteins, and therefore not to collect "bad" cholesterol.
The authors of the new methodology has already filed an application for registration of a patent. As noted by the developers, a campaign to reduce the level of cholesterol can be a real breakthrough in the field of medicine. The new drug is likely to become part of a comprehensive treatment.